期刊文献+

Botulinum Toxin Type A and Its Possible Mechanisms on Wound Healing

Botulinum Toxin Type A and Its Possible Mechanisms on Wound Healing
下载PDF
导出
摘要 Botulinum toxin type-A (BTX-A), a subtype from known seven types of botulinum neurotoxin (serotype A-G), is produced by a gram-positive bacterium, <i>Clostridium botulinum</i>. The toxin is now widely and efficiently used in treating a plethora of diverse symptoms and conditions. Recent evidence in the literature also shows that BTX-A exhibits a wide range of effects on non-neuronal cells. Its potential has markedly expanded to clinical applications other than the treatment of neurological and muscular conditions that are characterized by neuronal hyperactivity. A number of studies have shown BTX-A to improve the quality of scar outcome and prevent the formation of keloids and HTS. Although the mechanism of action of BTX-A on wound healing is still not clearly understood, lately there has been extensive research to grasp the underlying mechanisms of this multifunctional toxin. BTX-A seems to affect wound healing by a number of mechanisms that include action on tensile forces, inhibition of fibroblasts differentiation, downregulation of TGF-<i><span style="white-space:nowrap;">β</span></i>1 and collagen expression. This review will explore the responses of Botulinum toxin type-A on wound healing and preventing pathological scars like HTS and keloids, and comprehend the overall effect BTX-A has on wound healing. Botulinum toxin type-A (BTX-A), a subtype from known seven types of botulinum neurotoxin (serotype A-G), is produced by a gram-positive bacterium, <i>Clostridium botulinum</i>. The toxin is now widely and efficiently used in treating a plethora of diverse symptoms and conditions. Recent evidence in the literature also shows that BTX-A exhibits a wide range of effects on non-neuronal cells. Its potential has markedly expanded to clinical applications other than the treatment of neurological and muscular conditions that are characterized by neuronal hyperactivity. A number of studies have shown BTX-A to improve the quality of scar outcome and prevent the formation of keloids and HTS. Although the mechanism of action of BTX-A on wound healing is still not clearly understood, lately there has been extensive research to grasp the underlying mechanisms of this multifunctional toxin. BTX-A seems to affect wound healing by a number of mechanisms that include action on tensile forces, inhibition of fibroblasts differentiation, downregulation of TGF-<i><span style="white-space:nowrap;">β</span></i>1 and collagen expression. This review will explore the responses of Botulinum toxin type-A on wound healing and preventing pathological scars like HTS and keloids, and comprehend the overall effect BTX-A has on wound healing.
作者 Khushboo Gurung Qian Tan Ye Xu Bingchen Duan Khushboo Gurung;Qian Tan;Ye Xu;Bingchen Duan(Department of Burns, Plastic and Reconstructive Surgery, Nanjing Drum Tower Hospital, Affiliated to Medical School of Southeast University, Nanjing, China;Department of Burns, Plastic and Reconstructive Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University, Nanjing, China;Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China)
出处 《Modern Plastic Surgery》 2020年第3期38-55,共18页 现代整形外科(英文)
关键词 Wound Healing Botulinum Toxin Type-A Hypertrophic Scar KELOID FIBROBLAST MYOFIBROBLASTS Transforming Growth Factor <i>β</i>-1 Collagen METALLOPROTEINASES Connective Tissue Growth Factor Wound Healing Botulinum Toxin Type-A Hypertrophic Scar Keloid Fibroblast Myofibroblasts Transforming Growth Factor <i>β</i>-1 Collagen Metalloproteinases Connective Tissue Growth Factor
  • 相关文献

参考文献2

二级参考文献17

  • 1Zhu KQ,Carrougher GJ,Couture OP,et al.Expression of collaen genes in the cones of skin in the Duroc/Yorkshire porcine model fibroproliferafive scarring.J Burn Care lies,2008,29(5):815-827.
  • 2van der Veer WM,Bloemen MC,Ulrich MM,et al.Potential cellular and molecular causes of hypertrophic scar formtion.Bums,2009,35(1):15-29.
  • 3Goldberg SR,Quirk GL,Sykes VW,et al.Altered procollagen gene expression in mid-gestational mouse excisional wounds.J Surg Res,2007,143(1):27-34.
  • 4Cuttle L,Nataatmadja M,Fraser JF,et al.Collagen in the scarless fetal skin wound:detection with pieroeirins-polariztion.Wound Repair Regen,2005,13(2):198-204.
  • 5Kryger ZB,Sisco M,Roy NK,et al.Temporal expression of the transforming growth factor-beta pathway in the rabbit ear model of wound healing and scarring.J Am Coll Surg,2007,205(1):78-88.
  • 6Zhibo X,Miaobo Z.Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar.J Plast Reconstr Aesthetic Surg,2008,61(9):1128-1129.
  • 7Coltrini D, Rusnati M, Zoppetti G, et al. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies[J]. EurJ Biochem, 1993,214(1):51-58.
  • 8Cheng GC, Briggs WH, Gerson DS, et al. Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells[J].Circ Res, 1997,80(1):28-36.
  • 9Kletsas D, Basdra EK, Papavassiliou AG. Mechanical stress induces DNA synthesis in PDL fibroblasts by a mechanism unrelated to autocrine growth factor action[J].FEBS Lett, 1998,430(3):358-362.
  • 10LinksLi Q, Mumgaki Y, Hatamura I, et al.Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin Ⅱ and transforming growth factor-beta[J].J Vasc Res, 1998,35(2):93-103.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部